What is the current Aortic Endografts market size?

The Aortic Endografts market size is approximately USD 1.2 billion as of 2023.

What is the expected growth forecast for the Aortic Endografts market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the key drivers of the Aortic Endografts market?

Increasing demand for minimally invasive procedures drives the Aortic Endografts market.

What challenges does the Aortic Endografts market face?

High costs and limited reimbursement options challenge the Aortic Endografts market growth.

Which regions are leading the Aortic Endografts market?

North America and Europe are the leading regions in the Aortic Endografts market.

Who are the top companies in the Aortic Endografts market?

Medtronic and Gore are among the top companies in the Aortic Endografts market.

What future opportunities exist in the Aortic Endografts market?

Emerging markets and technological advancements offer future opportunities for growth.

How does technology impact the Aortic Endografts market?

Advances in material science and imaging technologies improve Aortic Endografts market outcomes.

What is the current regulatory landscape for the Aortic Endografts market?

Stringent regulatory approvals and compliance requirements govern the Aortic Endografts market.

What is the future outlook for the Aortic Endografts market?

The Aortic Endografts market is expected to experience steady growth due to increasing demand.

Aortic Endografts Growth, Trends & Forecast Outlook 2033

Aortic Endografts by Application (Hospitals, Clinics, Others), by Types (Abdominal Aortic Endografts, Thoracic Aortic Endografts, Fenestrated and Branched Aortic Endografts, Flow Diverting Aortic Endografts), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $4.8 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 18, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Aortic Endografts Market Overview

The Aortic Endografts market refers to the industry that produces and supplies endovascular stent grafts for the treatment of aortic diseases. As a critical component of minimally invasive vascular procedures, the Aortic Endografts market size is anticipated to experience significant growth, driven by advancements in medical technology and an increasing preference for minimally invasive procedures. The growth outlook for the Aortic Endografts market is promising, with a market forecast that indicates a compound annual growth rate (CAGR) of 7.3% from 2026 to 2033, driven by factors such as an aging population and an expanding patient base. The industry expansion is expected to be fueled by the development of new products and technologies, such as endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR).

Loading chart…

The current Aortic Endografts market size is estimated to be around $2.5 billion. Key forces shaping the industry include technology shifts, such as the development of new materials and designs, regulations, such as those related to device approval and reimbursement, and consumer behavior, such as an increasing demand for minimally invasive procedures. The largest region for Aortic Endografts is North America, while the fastest-growing region is expected to be Asia-Pacific, driven by an expanding patient base and increasing healthcare expenditure. Overall, the Aortic Endografts market is poised for significant growth, driven by a combination of macro drivers, including an aging population, an increasing prevalence of aortic diseases, and advancements in medical technology.

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 million
Revenue forecast in 2033	8.37 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bolton Medical; Braile Biomedica; Cardiatis; Cook Medical; Cordis (Cardinal Health); Endologix, Inc.; Endospan; Jotec; Lombard Medical Technologies Plc; Medtronic Plc; Microport Medical; Nano Endoluminal; Terumo Medical Corp.; Transcatheter Technologies; TriVascular Inc.; Vascutek; W. L. Gore & Associates
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Aortic Endografts market is poised for significant growth, driven by factors such as advancements in technology and increasing demand for minimally invasive procedures. The Aortic Endografts market size is expected to expand rapidly, with a substantial growth forecast, driven by the rising prevalence of aortic aneurysms and the growing need for effective treatment options.

Growth Drivers2 items

Advances in endovascular technology have improved the efficacy and safety of Aortic Endografts, leading to increased adoption rates among healthcare providers

The growing aging population and the subsequent rise in aortic aneurysm cases are driving demand for Aortic Endografts, contributing to the market's growth forecast

Restraints2 items

High device costs and limited reimbursement options are hindering the widespread adoption of Aortic Endografts, particularly in developing economies

Stringent regulatory requirements and rigorous testing protocols are increasing the time and cost associated with bringing new Aortic Endografts products to market, affecting the Aortic Endografts market size

Opportunities2 items

The development of customizable Aortic Endografts is expected to improve patient outcomes and drive market growth, as healthcare providers seek personalized treatment options

Emerging markets, such as Asia-Pacific, present significant opportunities for Aortic Endografts manufacturers, driven by growing demand for minimally invasive procedures and increasing healthcare expenditure

Challenges2 items

The Aortic Endografts market is highly competitive, with several established players, making it challenging for new entrants to gain market share and impacting the overall growth forecast

Managing supply chain risks and ensuring the consistent delivery of high-quality products are critical challenges facing Aortic Endografts manufacturers, particularly in the context of the Aortic Endografts market size

Market Segmentation

Loading chart…

The Aortic Endografts segmentation by application is a crucial aspect of the market taxonomy. It involves categorizing the market based on the specific use cases of aortic endografts, such as abdominal aortic aneurysm and thoracic aortic aneurysm. This segmentation helps in understanding the demand for aortic endografts in different therapeutic areas and identifying opportunities for growth.

The types of aortic endografts, including bare metal stents and covered stents, contribute significantly to the overall Aortic Endografts market size. These subtypes have distinct characteristics, such as material composition and design, which influence their adoption in various clinical settings. Analyzing these subtypes provides valuable insights into the market dynamics and trends, enabling stakeholders to make informed decisions.

Aortic Endografts Segmentation Breakdown9 items

Application

Hospitals

Clinics

Others

Types

Abdominal Aortic Endografts

Thoracic Aortic Endografts

Fenestrated and Branched Aortic Endografts

Flow Diverting Aortic Endografts

Regional Insights

Loading chart…

The Aortic Endografts market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of endovascular procedures, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - demographics with an aging population, ecosystem maturity with established healthcare systems, and high adoption rates of advanced medical technologies. Europe - regional forecast indicates a steady growth rate, driven by investments in research and development, and a strong ecosystem of medical device manufacturers. Asia Pacific - infrastructure development, increasing adoption of minimally invasive procedures, and growing demand for advanced medical devices. Latin America - policies supporting healthcare expansion, rising demand for endovascular treatments, and increasing adoption of medical technologies. Middle East & Africa - investments in healthcare infrastructure, growing demand for advanced medical devices, and increasing adoption of endovascular procedures.

Regional Insights3 items

North America: largest region, driven by demographics and ecosystem maturity

Asia Pacific: fastest-growing region, driven by adoption and investments

Europe: steady growth rate, driven by investments and ecosystem

Competitive Landscape

The Aortic Endografts market is moderately consolidated, driven by a mix of global players and local companies. The Aortic Endografts competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players are focusing on product innovation and regulatory approvals to maintain their market position, while local companies are relying on pricing and distribution strategies to compete.

Companies in the Aortic Endografts market are adopting various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. However, they face challenges such as margin pressure, compliance costs, and commoditization. To stay competitive, companies are focusing on technology, service model, channel strength, customization, and cost advantages. The following companies are implementing different strategies to stay ahead in the market:

Bolton Medical: regional expansion

Cook Medical: premium pricing

Medtronic Plc: innovation pipeline

W. L. Gore & Associates: local manufacturing

Endologix, Inc.: vertical integration

Cardiatis: OEM tie-ups

Key Aortic Endografts Companies17 items

Bolton Medical

Braile Biomedica

Cardiatis

Cook Medical

Cordis (Cardinal Health)

Endologix, Inc.

Endospan

Jotec

Lombard Medical Technologies Plc

Medtronic Plc

Microport Medical

Nano Endoluminal

Terumo Medical Corp.

Transcatheter Technologies

TriVascular Inc.

Vascutek

W. L. Gore & Associates

Market Ecosystem

The Aortic Endografts ecosystem spans across upstream, midstream, and downstream segments, encompassing technology providers, suppliers, integrators, channels, and end users. This complex network creates and captures value through the development, manufacturing, and distribution of aortic endografts, ultimately delivering these medical devices to patients in need. Understanding the Aortic Endografts ecosystem is crucial for conducting a comprehensive value chain analysis.

Raw material suppliers — providing implantable materials

OEMs / manufacturers — designing and producing endografts

Technology providers — offering innovative stent graft designs

System integrators / EPCs — integrating endografts with delivery systems

Distributors / channel partners — supplying endografts to hospitals

Service providers / after-sales — providing training and support

Regulators/standards bodies — overseeing safety and efficacy standards

The flow of value within the Aortic Endografts ecosystem is influenced by various control points, including regulatory approvals, reimbursement policies, and clinician adoption. Dependency risks, such as limited supplier options for critical components or stringent regulatory requirements, can impact the ecosystem's efficiency. Furthermore, switching costs and interoperability requirements may hinder the introduction of new technologies or market entrants. The ecosystem's dynamics can also vary by region, with different healthcare systems and regulatory frameworks affecting the adoption and use of aortic endografts.

Recent Industry Insights

The Aortic Endografts industry has witnessed significant developments over the last 12-18 months, shaping Aortic Endografts industry trends. Notable partnerships have been formed, such as collaborations between medical device manufacturers and research institutions, to advance endograft technology. Furthermore, there have been strategic mergers and acquisitions, enhancing the market presence of key players. Recent product launches have also introduced innovative features, including improved durability and minimally invasive deployment systems.

Additionally, regulatory changes have expanded the indication of certain endografts, increasing their adoption. A shift in consumer trends towards minimally invasive procedures has driven the demand for advanced aortic endografts. The industry has also seen significant funding rounds, with investors backing companies developing next-generation endograft technologies. These developments are expected to continue influencing the trajectory of the Aortic Endografts industry, with a focus on innovation and patient-centric solutions.

Analyst Overview

As the Lead Analyst for this study, my expert view on the Aortic Endografts market outlook is that it presents a highly attractive opportunity for growth, driven by an increasing prevalence of aortic aneurysms and advancements in medical technology. The competitive intensity in this market is moderate, with key players focusing on innovation and expansion of their product portfolios. Looking ahead, the long-term outlook for the Aortic Endografts market is promising, with ongoing research and development expected to drive growth and improve patient outcomes.

The innovation landscape is rapidly evolving, with a focus on developing more sophisticated and minimally invasive endografts. However, the demand–supply balance may be challenged by regulatory hurdles and varying reimbursement landscapes. Key risk factors include technological failures and intense competition, which may impact market growth. Overall, the Aortic Endografts market outlook is positive, with opportunities for growth and innovation driven by advances in medical technology and an increasing demand for effective treatments.

11 items

1. Executive Summary

2. Aortic Endografts Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Aortic Endografts Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Aortic Endografts Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Clinics

6.1.3. Others

6.2. Global Aortic Endografts Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Abdominal Aortic Endografts

6.2.2. Thoracic Aortic Endografts

6.2.3. Fenestrated and Branched Aortic Endografts

6.2.4. Flow Diverting Aortic Endografts

6.3. Global Aortic Endografts Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Aortic Endografts Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Aortic Endografts Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Aortic Endografts Market Competition by Key Manufacturers

8.1. Global Aortic Endografts Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Aortic Endografts: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Bolton Medical

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. Braile Biomedica

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Cardiatis

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Cook Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Cordis (Cardinal Health)

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Endologix, Inc.

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Endospan

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Jotec

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Lombard Medical Technologies Plc

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Medtronic Plc

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. Microport Medical

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. Nano Endoluminal

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Terumo Medical Corp.

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. Transcatheter Technologies

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. TriVascular Inc.

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

9.16. Vascutek

9.16.1. Company Basic Information and Sales Area

9.16.2. Main Business/Business Overview

9.16.3. Product Portfolio

9.16.4. Financial

9.16.5. Recent Industry Insights

9.16.6. SWOT Analysis

9.17. W. L. Gore & Associates

9.17.1. Company Basic Information and Sales Area

9.17.2. Main Business/Business Overview

9.17.3. Product Portfolio

9.17.4. Financial

9.17.5. Recent Industry Insights

9.17.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Aortic Endografts Market

Figure 4: Global Aortic Endografts Market: Drivers

Figure 5: Global Aortic Endografts Market: Challenges

Figure 6: Global Aortic Endografts Market: Trends

Figure 7: Global Aortic Endografts Market: Opportunity

Figure 8: Global Aortic Endografts Market: Restraint

Figure 9: Global Aortic Endografts Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Aortic Endografts Market Value (USD Million) By Region

Figure 15: Global Aortic Endografts Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Aortic Endografts Market Value (USD Million) By Region

Figure 23: Global Aortic Endografts Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

87 items

Table 1: Market Segmentation Analysis

Table 2: Global Aortic Endografts Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Aortic Endografts Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Aortic Endografts Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Aortic Endografts Market Value (USD Million) By Region

Table 10: Global Aortic Endografts Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Aortic Endografts Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Aortic Endografts Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Aortic Endografts Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Bolton Medical Basic Information And Sales Area

Table 31: Bolton Medical. Products Portfolio

Table 32: Braile Biomedica Basic Information And Sales Area

Table 33: Braile Biomedica. Products Portfolio

Table 34: Cardiatis Basic Information And Sales Area

Table 35: Cardiatis. Products Portfolio

Table 36: Cook Medical Basic Information And Sales Area

Table 37: Cook Medical. Products Portfolio

Table 38: Cordis (Cardinal Health) Basic Information And Sales Area

Table 39: Cordis (Cardinal Health). Products Portfolio

Table 40: Endologix, Inc. Basic Information And Sales Area

Table 41: Endologix, Inc.. Products Portfolio

Table 42: Endospan Basic Information And Sales Area

Table 43: Endospan. Products Portfolio

Table 44: Jotec Basic Information And Sales Area

Table 45: Jotec. Products Portfolio

Table 46: Lombard Medical Technologies Plc Basic Information And Sales Area

Table 47: Lombard Medical Technologies Plc. Products Portfolio

Table 48: Medtronic Plc Basic Information And Sales Area

Table 49: Medtronic Plc. Products Portfolio

Table 50: Microport Medical Basic Information And Sales Area

Table 51: Microport Medical. Products Portfolio

Table 52: Nano Endoluminal Basic Information And Sales Area

Table 53: Nano Endoluminal. Products Portfolio

Table 54: Terumo Medical Corp. Basic Information And Sales Area

Table 55: Terumo Medical Corp.. Products Portfolio

Table 56: Transcatheter Technologies Basic Information And Sales Area

Table 57: Transcatheter Technologies. Products Portfolio

Table 58: TriVascular Inc. Basic Information And Sales Area

Table 59: TriVascular Inc.. Products Portfolio

Table 60: Vascutek Basic Information And Sales Area

Table 61: Vascutek. Products Portfolio

Table 62: W. L. Gore & Associates Basic Information And Sales Area

Table 63: W. L. Gore & Associates. Products Portfolio

Table 64: Global Market Value (USD Million) (2025-2032) By Application

Table 65: Global Market Share (%) By Application (2032)

Table 66: Global Market Value (USD Million) (2025-2032) By Types

Table 67: Global Market Share (%) By Types (2032)

Table 68: Global Aortic Endografts Market Value (USD Million) By Region

Table 69: Global Aortic Endografts Market Share (%) By Region (2025-2032)

Table 70: North America Market Value (USD Million) (2025-2032) By Country

Table 71: North America Market Value (USD Million) (2025-2032) By Application

Table 72: North America Market Value (USD Million) (2025-2032) By Types

Table 73: Europe Market Value (USD Million) (2025-2032) By Country

Table 74: Europe Market Value (USD Million) (2025-2032) By Application

Table 75: Europe Market Value (USD Million) (2025-2032) By Types

Table 76: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 77: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 78: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 79: South America Market Value (USD Million) (2025-2032) By Country

Table 80: South America Market Value (USD Million) (2025-2032) By Application

Table 81: South America Market Value (USD Million) (2025-2032) By Types

Table 82: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 83: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 84: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 85: Research Programs/Design For This Report

Table 86: Key Data Information From Secondary Sources

Table 87: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Aortic Endografts Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	4.80 million
Revenue forecast in 2033	8.37 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Bolton Medical; Braile Biomedica; Cardiatis; Cook Medical; Cordis (Cardinal Health); Endologix, Inc.; Endospan; Jotec; Lombard Medical Technologies Plc; Medtronic Plc; Microport Medical; Nano Endoluminal; Terumo Medical Corp.; Transcatheter Technologies; TriVascular Inc.; Vascutek; W. L. Gore & Associates
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in endovascular technology have improved the efficacy and safety of Aortic Endografts, leading to increased adoption rates among healthcare providers

The growing aging population and the subsequent rise in aortic aneurysm cases are driving demand for Aortic Endografts, contributing to the market's growth forecast

Restraints2 items

High device costs and limited reimbursement options are hindering the widespread adoption of Aortic Endografts, particularly in developing economies

Opportunities2 items

The development of customizable Aortic Endografts is expected to improve patient outcomes and drive market growth, as healthcare providers seek personalized treatment options

Challenges2 items

The Aortic Endografts market is highly competitive, with several established players, making it challenging for new entrants to gain market share and impacting the overall growth forecast

Market Segmentation

Loading chart…

Aortic Endografts Segmentation Breakdown9 items

Application

Hospitals

Clinics

Others

Types

Abdominal Aortic Endografts

Thoracic Aortic Endografts

Fenestrated and Branched Aortic Endografts

Flow Diverting Aortic Endografts

Regional Insights

Loading chart…

Regional Insights3 items

North America: largest region, driven by demographics and ecosystem maturity

Asia Pacific: fastest-growing region, driven by adoption and investments

Europe: steady growth rate, driven by investments and ecosystem

Competitive Landscape

Bolton Medical: regional expansion

Cook Medical: premium pricing

Medtronic Plc: innovation pipeline

W. L. Gore & Associates: local manufacturing

Endologix, Inc.: vertical integration

Cardiatis: OEM tie-ups

Key Aortic Endografts Companies17 items

Bolton Medical

Braile Biomedica

Cardiatis

Cook Medical

Cordis (Cardinal Health)

Endologix, Inc.

Endospan

Jotec

Lombard Medical Technologies Plc

Medtronic Plc

Microport Medical

Nano Endoluminal

Terumo Medical Corp.

Transcatheter Technologies

TriVascular Inc.

Vascutek

W. L. Gore & Associates

Market Ecosystem

Raw material suppliers — providing implantable materials

OEMs / manufacturers — designing and producing endografts

Technology providers — offering innovative stent graft designs

System integrators / EPCs — integrating endografts with delivery systems

Distributors / channel partners — supplying endografts to hospitals

Service providers / after-sales — providing training and support

Regulators/standards bodies — overseeing safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents